Nuzenio

Jazz Pharma Expands

Jazz Pharma Expands news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Jazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition - MedCity NewsMedCity News · Mon, 10 Aug 2026 22:02:41 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Mon, 10 Aug 2026 16:17:36 GMTJazz expands epilepsy portfolio with buy of Actio Biosciences - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 15:16:17 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 10 Aug 2026 14:22:59 GMTJazz Pharmaceuticals to Acquire Actio Biosciences in Deal Worth Up to $1.32 Billion - citybizcitybiz · Mon, 10 Aug 2026 13:11:44 GMTJazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:30:00 GMTOligonucleotide Therapeutics Market Size, Share - Forecast To 2035 - Business Research InsightsBusiness Research Insights · Mon, 10 Aug 2026 09:40:04 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMT

Timeline

Mon, 10 Aug 2026 22:02:41 GMTJazz Pharma Expands Again in Epilepsy With $850M Actio Bio Acquisition - MedCity News
Mon, 10 Aug 2026 16:17:36 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical Review
Mon, 10 Aug 2026 15:16:17 GMTJazz expands epilepsy portfolio with buy of Actio Biosciences - The Pharma Letter
Mon, 10 Aug 2026 14:22:59 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - Pharmaceutical Executive
Mon, 10 Aug 2026 13:11:44 GMTJazz Pharmaceuticals to Acquire Actio Biosciences in Deal Worth Up to $1.32 Billion - citybiz
Mon, 10 Aug 2026 11:30:00 GMTJazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR Newswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Jazz Pharma Expands.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.